DACH1 and lung adenocarcinoma: Considering our experimental results and previous publications, it can be concluded that the inhibitory role of DACH1 in the proliferation and invasion of lung adenocarcinoma should be ascribed to the downregulation of its transcriptional target, Prx3, by competing with FOXM1 for promoter binding.